U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    Mir9-2 microRNA 9-2 [ Mus musculus (house mouse) ]

    Gene ID: 723967, updated on 4-Jan-2025

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Propofol induces the apoptosis of neural stem cells via microRNA-9-5p / chemokine CXC receptor 4 signaling pathway.

    Propofol induces the apoptosis of neural stem cells via microRNA-9-5p / chemokine CXC receptor 4 signaling pathway.
    Zhang W, Liu Q, Zhu H, Ma C, Luo Q, Ji M, Liu L., Free PMC Article

    02/26/2022
    miR-9-5p regulates immunometabolic and epigenetic pathways in beta-glucan-trained immunity via IDH3alpha.

    miR-9-5p regulates immunometabolic and epigenetic pathways in β-glucan-trained immunity via IDH3α.
    Su H, Liang Z, Weng S, Sun C, Huang J, Zhang T, Wang X, Wu S, Zhang Z, Zhang Y, Gong Q, Xu Y., Free PMC Article

    02/19/2022
    microRNAs (miR 9, 124, 155 and 224) transdifferentiate mouse macrophages to neurons.

    microRNAs (miR 9, 124, 155 and 224) transdifferentiate mouse macrophages to neurons.
    Challagundla N, Agrawal-Rajput R.

    09/25/2021
    MiR-9-5p inhibits mitochondrial damage and oxidative stress in AD cell models by targeting GSK-3beta.

    MiR-9-5p inhibits mitochondrial damage and oxidative stress in AD cell models by targeting GSK-3β.
    Liu J, Zuo X, Han J, Dai Q, Xu H, Liu Y, Cui S.

    05/22/2021
    MicroRNA-9 overexpression suppresses vulnerable atherosclerotic plaque and enhances vascular remodeling through negative regulation of the p38MAPK pathway via OLR1 in acute coronary syndrome.

    MicroRNA-9 overexpression suppresses vulnerable atherosclerotic plaque and enhances vascular remodeling through negative regulation of the p38MAPK pathway via OLR1 in acute coronary syndrome.
    Yu DR, Wang T, Huang J, Fang XY, Fan HF, Yi GH, Liu Q, Zhang Y, Zeng XZ, Liu QB.

    02/27/2021
    Antinociceptive effect of intrathecal injection of miR-9-5p modified mouse bone marrow mesenchymal stem cells on a mouse model of bone cancer pain.

    Antinociceptive effect of intrathecal injection of miR-9-5p modified mouse bone marrow mesenchymal stem cells on a mouse model of bone cancer pain.
    Zhu C, Wang K, Chen Z, Han Y, Chen H, Li Q, Liu Z, Qian L, Tang J, Shen H., Free PMC Article

    12/12/2020
    Silence of MiR-9 protects depression mice through Notch signaling pathway.

    Silence of MiR-9 protects depression mice through Notch signaling pathway.
    Ma ZY, Chen F, Xiao P, Zhang XM, Gao XX.

    09/26/2020
    The long non-coding RNA TUG1-miR-9a-5p axis contributes to ischemic injuries by promoting cardiomyocyte apoptosis via targeting KLF5.

    The long non-coding RNA TUG1-miR-9a-5p axis contributes to ischemic injuries by promoting cardiomyocyte apoptosis via targeting KLF5.
    Yang D, Yu J, Liu HB, Yan XQ, Hu J, Yu Y, Guo J, Yuan Y, Du ZM., Free PMC Article

    09/5/2020
    our data manifested that KCNQ1OT1 possibly acts as a facilitator in cerebral I/R injury through modulating miR-9/MMP8 axis as a ceRNA

    LncRNA KCNQ1OT1 contributes to oxygen-glucose-deprivation/reoxygenation-induced injury via sponging miR-9 in cultured neurons to regulate MMP8.
    Ren Y, Gao XP, Liang H, Zhang H, Hu CY.

    07/18/2020
    the present study proved that overexpression of miR-9-5p suppressed chondrocytes apoptosis and promoted cartilage remodeling through downregulating of Tnc in mice with osteoarthritis

    Upregulation of microRNA-9-5p inhibits apoptosis of chondrocytes through downregulating Tnc in mice with osteoarthritis following tibial plateau fracture.
    Chen H, Yang J, Tan Z.

    06/13/2020
    miR-9 negative regulated diaphanous homologous protein 1, a key organizer of the actin cytoskeletal assembly.

    MicroRNA-mediated disruption of dendritogenesis during a critical period of development influences cognitive capacity later in life.
    Lin Q, Ponnusamy R, Widagdo J, Choi JA, Ge W, Probst C, Buckley T, Lou M, Bredy TW, Fanselow MS, Ye K, Sun YE., Free PMC Article

    07/28/2018
    BAF (BRG1/BRM-Associated Factor) chromatin-remodeling complex may adaptively respond to ethanol exposure to protect against a complete loss of miR-9-2 in fetal neural stem cells.

    The BAF (BRG1/BRM-Associated Factor) chromatin-remodeling complex exhibits ethanol sensitivity in fetal neural progenitor cells and regulates transcription at the miR-9-2 encoding gene locus.
    Burrowes SG, Salem NA, Tseng AM, Balaraman S, Pinson MR, Garcia C, Miranda RC., Free PMC Article

    02/10/2018
    HDAC5 emerges as a cellular conductor of MEF2C and M6a activity and is regulated by miR-124 and miR-9 to control neurite development.

    miR-124 and miR-9 mediated downregulation of HDAC5 promotes neurite development through activating MEF2C-GPM6A pathway.
    Gu X, Fu C, Lin L, Liu S, Su X, Li A, Wu Q, Jia C, Zhang P, Chen L, Zhu X, Wang X.

    10/28/2017
    Collectively, miR-9 promotes osteoblast differentiation of mesenchymal stem cells by suppressing DKK1 gene expression.

    MiR-9 promotes osteoblast differentiation of mesenchymal stem cells by inhibiting DKK1 gene expression.
    Liu X, Xu H, Kou J, Wang Q, Zheng X, Yu T.

    02/25/2017
    Ngn1 binds to the promoter of a brain-enriched microRNA, miR-9, and activates its expression during neurogenesis.

    Ngn1 inhibits astrogliogenesis through induction of miR-9 during neuronal fate specification.
    Zhao J, Lin Q, Kim KJ, Dardashti FD, Kim J, He F, Sun Y., Free PMC Article

    07/2/2016
    Reduced miR-9 and miR-181a expression down-regulates Bim concentration and promotes survival of osteoclasts from fractured tibias.

    Reduced miR-9 and miR-181a expression down-regulates Bim concentration and promote osteoclasts survival.
    Wang S, Tang C, Zhang Q, Chen W., Free PMC Article

    02/28/2015
    Upregulation of miR-92a promotes endothelial activation and the development of atherosclerotic lesions.

    Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.
    Loyer X, Potteaux S, Vion AC, Guérin CL, Boulkroun S, Rautou PE, Ramkhelawon B, Esposito B, Dalloz M, Paul JL, Julia P, Maccario J, Boulanger CM, Mallat Z, Tedgui A.

    03/29/2014
    firstprevious page of 1 nextlast